PubRank

James R Baker

Author PubWeight™ 195.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 2005 4.71
2 The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 2007 3.36
3 Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 2006 2.87
4 Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 2004 2.66
5 Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res 2007 2.34
6 Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem 2005 2.32
7 Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 2002 2.30
8 PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 2006 2.17
9 Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol 2005 2.05
10 Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 2005 1.97
11 Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett 2008 1.96
12 Protein modification, bioconjugation, and disulfide bridging using bromomaleimides. J Am Chem Soc 2010 1.89
13 Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem 2005 1.80
14 Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 2002 1.77
15 Applications of nanotechnology for immunology. Nat Rev Immunol 2013 1.65
16 Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group. Langmuir 2005 1.56
17 Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007 1.45
18 Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids 2004 1.42
19 Bromomaleimides: new reagents for the selective and reversible modification of cysteine. Chem Commun (Camb) 2009 1.40
20 Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis. Chem Commun (Camb) 2011 1.38
21 Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists. Ann Allergy Asthma Immunol 2005 1.38
22 HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjug Chem 2006 1.36
23 In situ maleimide bridging of disulfides and a new approach to protein PEGylation. Bioconjug Chem 2011 1.33
24 Dendrimer-epidermal growth factor conjugate displays superagonist activity. Biomacromolecules 2008 1.31
25 A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. ACS Nano 2010 1.29
26 Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomedicine 2008 1.28
27 Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Infect Immun 2007 1.27
28 Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. J Phys Chem B 2009 1.27
29 Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjug Chem 2004 1.24
30 Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers. ACS Nano 2008 1.22
31 The role of apoptosis in thyroid autoimmunity. Thyroid 2007 1.20
32 Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys 2007 1.20
33 Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One 2008 1.20
34 Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2008 1.18
35 Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion. Vaccine 2003 1.17
36 Real-time biomolecular binding detection using a sensitive photonic crystal biosensor. Anal Chem 2010 1.17
37 Bromopyridazinedione-mediated protein and peptide bioconjugation. Chem Commun (Camb) 2011 1.15
38 Sensitive molecular binding assay using a photonic crystal structure in total internal reflection. Opt Express 2008 1.14
39 Current dendrimer applications in cancer diagnosis and therapy. Curr Top Med Chem 2008 1.14
40 Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 2005 1.13
41 In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. Biomacromolecules 2004 1.13
42 Two-photon fluorescence correlation spectroscopy through a dual-clad optical fiber. Opt Express 2008 1.12
43 Isolation and characterization of dendrimers with precise numbers of functional groups. Chemistry 2010 1.11
44 Bromomaleimide-linked bioconjugates are cleavable in mammalian cells. Chembiochem 2011 1.09
45 HPLC analysis of PAMAM dendrimer based multifunctional devices. J Chromatogr B Analyt Technol Biomed Life Sci 2005 1.07
46 Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant. Crit Rev Immunol 2010 1.07
47 Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures. Bioconjug Chem 2007 1.06
48 The role of ganglioside GM1 in cellular internalization mechanisms of poly(amidoamine) dendrimers. Bioconjug Chem 2009 1.05
49 Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate. Chem Commun (Camb) 2010 1.04
50 A novel, killed-virus nasal vaccinia virus vaccine. Clin Vaccine Immunol 2007 1.03
51 Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum 2011 1.03
52 Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules 2007 1.03
53 Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations. Biomacromolecules 2009 1.03
54 Poly(amidoamine) dendrimers on lipid bilayers I: Free energy and conformation of binding. J Phys Chem B 2008 1.02
55 In Vivo Monitoring of Multiple Circulating Cell Populations Using Two-photon Flow Cytometry. Opt Commun 2008 1.02
56 A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease. PLoS One 2011 1.02
57 Quantitative two-photon flow cytometry--in vitro and in vivo. J Biomed Opt 2008 1.01
58 Quantitative analysis of generation and branch defects in G5 poly(amidoamine) dendrimer. Polymer (Guildf) 2013 1.00
59 The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles. Bioconjug Chem 2008 1.00
60 Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010 1.00
61 Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'. Sci Rep 2013 0.99
62 The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi. Mycopathologia 2002 0.98
63 Best practices for purification and characterization of PAMAM dendrimer. Macromolecules 2012 0.98
64 Polymeric dibromomaleimides as extremely efficient disulfide bridging bioconjugation and pegylation agents. J Am Chem Soc 2012 0.98
65 Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model. Hum Vaccin 2010 0.98
66 Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging. Biomacromolecules 2009 0.97
67 Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Anticancer Drugs 2008 0.97
68 Molecular dynamics studies of the size, shape, and internal structure of 0% and 90% acetylated fifth-generation polyamidoamine dendrimers in water and methanol. J Phys Chem B 2006 0.97
69 HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups. Anal Chem 2005 0.96
70 A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 2002 0.96
71 IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Oncogene 2004 0.95
72 Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery. Bioorg Med Chem Lett 2010 0.94
73 Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate. J Biomater Sci Polym Ed 2008 0.94
74 Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking. Eur J Immunol 2012 0.94
75 HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb. Nanotechnology 2008 0.94
76 Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform. Tetrahedron Lett 2011 0.93
77 Development of a remanence measurement-based SQUID system with in-depth resolution for nanoparticle imaging. Phys Med Biol 2009 0.93
78 Detection and analysis of tumor fluorescence using a two-photon optical fiber probe. Biophys J 2004 0.93
79 Methotrexate delivery via folate targeted dendrimer-based nanotherapeutic platform. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010 0.93
80 HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein. Analyst 2006 0.92
81 Dendrimer-based BH3 conjugate that targets human carcinoma cells. Biomacromolecules 2007 0.92
82 Efficacy assessment of Aphidius colemani (Hymenoptera: Braconidae) for suppression of Aphis gossypii (Homoptera: Aphididae) in greenhouse-grown chrysanthemum. J Econ Entomol 2006 0.92
83 Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery 2010 0.92
84 Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo. Anticancer Drugs 2010 0.91
85 The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway. Mol Pharm 2010 0.91
86 Fiber-optic multiphoton flow cytometry in whole blood and in vivo. J Biomed Opt 2010 0.91
87 Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate. Photochem Photobiol Sci 2012 0.91
88 Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting. Eur J Med Chem 2011 0.91
89 Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant. Clin Vaccine Immunol 2011 0.91
90 The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release. Org Lett 2010 0.91
91 Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 2005 0.91
92 The facile synthesis of multifunctional PAMAM dendrimer conjugates through copper-free click chemistry. Bioorg Med Chem Lett 2012 0.91
93 Stoichiometry and Structure of Poly(amidoamine) Dendrimer-Lipid Complexes. ACS Nano 2009 0.90
94 Investigation of tumor cell targeting of a dendrimer nanoparticle using a double-clad optical fiber probe. J Biomed Opt 2008 0.90
95 Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio. Biomacromolecules 2012 0.90
96 In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother 2008 0.90
97 Electrophoretic mobility and molecular distribution studies of poly(amidoamine) dendrimers of defined charges. Electrophoresis 2006 0.90
98 Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer. Cell Cycle 2005 0.89
99 RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies. Bioconjug Chem 2009 0.89
100 Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold Nanoparticles. J Phys Chem C Nanomater Interfaces 2009 0.89
101 Prevention of influenza pneumonitis by sialic Acid-conjugated dendritic polymers. J Infect Dis 2002 0.88
102 Trapping cavitation bubbles with a self-focused laser beam. Opt Lett 2004 0.88
103 Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging. Org Biomol Chem 2014 0.87
104 Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices. Mol Pharm 2005 0.87
105 A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones. Tetrahedron Lett 2013 0.87
106 Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano 2012 0.87
107 Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol 2003 0.87
108 Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation. Chem Commun (Camb) 2013 0.86
109 Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody-drug conjugate (ADC). Chem Commun (Camb) 2015 0.86
110 Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform. Bioconjug Chem 2011 0.86
111 Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology 2008 0.86
112 Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. J Immunol 2014 0.86
113 Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis. Analyst 2006 0.86
114 Dendrimer-based tumor cell targeting of fibroblast growth factor-1. Bioorg Med Chem Lett 2009 0.86
115 Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study. ACS Med Chem Lett 2011 0.86
116 Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013 0.86
117 Adverse reactions to vaccines. Ann Allergy Asthma Immunol 2009 0.85
118 Analysis of poly(amidoamine)-succinamic acid dendrimers by slab-gel electrophoresis and capillary zone electrophoresis. Electrophoresis 2005 0.85
119 Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter 2010 0.85
120 Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine 2012 0.85
121 Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers. Macromol Biosci 2009 0.85
122 A photochemical approach for controlled drug release in targeted drug delivery. Bioorg Med Chem 2011 0.85
123 Control of two-photon fluorescence of common dyes and conjugated dyes. J Fluoresc 2008 0.85
124 A Facile Hydrothermal Synthesis of Iron Oxide Nanoparticles with Tunable Magnetic Properties. J Phys Chem C Nanomater Interfaces 2009 0.84
125 Interactions of poly(amidoamine) dendrimers with Survanta lung surfactant: the importance of lipid domains. Langmuir 2008 0.84
126 Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 2004 0.84
127 Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines. J Aerosol Med Pulm Drug Deliv 2010 0.84
128 Interleukin-1beta and tumor necrosis factor (TNF)-alpha sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity. J Clin Endocrinol Metab 2004 0.84
129 Reversible protein affinity-labelling using bromomaleimide-based reagents. Org Biomol Chem 2013 0.83
130 Extended cavity laser enhanced two-photon flow cytometry. J Biomed Opt 2008 0.83
131 Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification. Chem Commun (Camb) 2013 0.83
132 Encapsulation of submicrometer-sized 2-methoxyestradiol crystals into polymer multilayer capsules for biological applications. Mol Pharm 2006 0.83
133 4-Hydroxytamoxifen probes for light-dependent spatiotemporal control of Cre-ER mediated reporter gene expression. Mol Biosyst 2014 0.83
134 Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma. J Oral Maxillofac Surg 2011 0.83
135 [2+2] photocycloadditions of thiomaleimides. Chem Commun (Camb) 2012 0.83
136 Design considerations for PAMAM dendrimer therapeutics. Bioorg Med Chem Lett 2013 0.83
137 Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells. Vaccine 2012 0.83
138 Highly efficient disulfide bridging polymers for bioconjugates from radical-compatible dithiophenol maleimides. Chem Commun (Camb) 2012 0.83
139 Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs. Bioorg Med Chem Lett 2009 0.83
140 Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity. Mol Pharm 2013 0.83
141 OT-II TCR transgenic mice fail to produce anti-ovalbumin antibodies upon vaccination. Cell Immunol 2013 0.83
142 Evaluating binding avidities of populations of heterogeneous multivalent ligand-functionalized nanoparticles. ACS Nano 2014 0.82
143 Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach. Bioconjug Chem 2010 0.82
144 Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology 2007 0.82
145 Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent. Bioorg Med Chem 2011 0.82
146 No apparent damage in the thyroid of transgenic mice expressing antiapoptotic FLIP. Thyroid 2006 0.82
147 Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action. Biomacromolecules 2013 0.81
148 Whole spectrum fluorescence detection with ultrafast white light excitation. Opt Express 2007 0.81
149 CE of poly(amidoamine) succinamic acid dendrimers using a poly(vinyl alcohol)-coated capillary. Electrophoresis 2008 0.81
150 Targeting B cells in Graves' disease. Endocrinology 2006 0.81
151 Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic. Curr Pharm Des 2013 0.80
152 Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen. Nanomedicine (Lond) 2012 0.80
153 Acid-catalyzed rearrangement of fused alkylideneoxetanols. Org Lett 2007 0.80
154 Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles. Analyst 2009 0.80
155 New Dendrimers: Synthesis and Characterization of Popam - Pamam Hybrid Dendrimers. Macromolecules 2008 0.79
156 Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions. Macromolecules 2010 0.79
157 Sustained analgesia achieved through esterase-activated morphine prodrugs complexed with PAMAM dendrimer. Pharm Res 2012 0.79
158 Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division. Mol Pharm 2013 0.79
159 Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells. Biopolymers 2009 0.79
160 Bromo- and thiomaleimides as a new class of thiol-mediated fluorescence 'turn-on' reagents. Org Biomol Chem 2014 0.79
161 A platform for efficient, thiol-stable conjugation to albumin's native single accessible cysteine. Org Biomol Chem 2015 0.78
162 Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery. Biomacromolecules 2012 0.78
163 The design, synthesis and pharmacological characterization of novel β₂-adrenoceptor antagonists. Br J Pharmacol 2011 0.78
164 Treatment with a novel topical nanoemulsion (NB-001) speeds time to healing of recurrent cold sores. J Drugs Dermatol 2012 0.78
165 Control of the blue fluorescent protein with advanced evolutionary pulse shaping. Biochem Biophys Res Commun 2008 0.78
166 Tumor microvasculature targeting with dendrimer-entrapped gold nanoparticles. Soft Matter 2008 0.78
167 Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography. Anal Methods 2011 0.78
168 Homogeneous bispecifics by disulfide bridging. Bioconjug Chem 2014 0.78
169 Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds. Chem Commun (Camb) 2014 0.78
170 A one-step procedure for the monoacylation of symmetrical 1,2-diols. J Org Chem 2002 0.78
171 Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. J Clin Immunol 2014 0.78
172 Quantitative differentiation of dyes with overlapping one-photon spectra by femtosecond pulse shaping. J Lumin 2010 0.78
173 Specific and cooperative interactions between oximes and PAMAM dendrimers as demonstrated by (1)H NMR study. J Phys Chem B 2012 0.78
174 Capillary electrophoresis of polycationic poly(amidoamine) dendrimers. Electrophoresis 2005 0.77
175 Synthesis and evaluation of highly potent GABA(A) receptor antagonists based on gabazine (SR-95531). Bioorg Med Chem Lett 2011 0.77
176 The need to pursue and publish clinical trials in nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011 0.77
177 Optical fiber-based in vivo quantification of growth factor receptors. Cancer 2011 0.77
178 Profiling inflammatory responses with microfluidic immunoblotting. PLoS One 2013 0.76
179 Surface interaction and behavior of poly(amidoamine) dendrimers: deformability and lipid bilayer disruption. J Comput Theor Nanosci 2009 0.76
180 A dual optical and nuclear imaging reagent for peptide labelling via disulfide bridging. Org Biomol Chem 2015 0.76
181 Photochemically re-bridging disulfide bonds and the discovery of a thiomaleimide mediated photodecarboxylation of C-terminal cysteines. Org Biomol Chem 2015 0.75
182 In situ reduction in photocycloadditions: a method to prevent secondary photoreactions. Org Lett 2009 0.75
183 Label-free biosensing using a photonic crystal structure in a total-internal-reflection geometry. Proc SPIE Int Soc Opt Eng 2009 0.75
184 Nanoemulsion Therapy for Burn Wounds Is Effective as a Topical Antimicrobial Against Gram-Negative and Gram-Positive Bacteria. J Burn Care Res 2016 0.75
185 Rapid access to azepine-fused oxetanols from alkoxy-substituted maleimides. Org Lett 2004 0.75
186 Multivalent dendrimer vectors with DNA intercalation motifs for gene delivery. Biomacromolecules 2014 0.75
187 Overexpression of BID in thyroids of transgenic mice increases sensitivity to iodine-induced autoimmune thyroiditis. J Transl Med 2014 0.75
188 Interactive Design Strategy for a Multi-Functional PAMAM Dendrimer-Based Nano-Therapeutic Using Computational Models and Experimental Analysis. J Comput Theor Nanosci 2009 0.75
189 Fluorogenic 'click-on' dendrimer reporter for rapid profiling of cell proliferation. Bioorg Med Chem Lett 2013 0.75
190 Quality assessment of selected commercially available whitefly and aphid biological control agents in the United States. J Econ Entomol 2004 0.75
191 Diffusion of Alexa Fluor 488-conjugated dendrimers in rat aortic tissue. Ann N Y Acad Sci 2006 0.75
192 Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel. J Acad Nutr Diet 2017 0.75
193 Synthetic strategies to epoxydiynes and a key synthon of the neocarzinostatin chromophore. Org Biomol Chem 2007 0.75
194 Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis. J Biomed Nanotechnol 2015 0.75
195 Plasma-mediated release of morphine from synthesized prodrugs. Bioorg Med Chem Lett 2010 0.75
196 A novel MEA/AFM platform for measurement of real-time, nanometric morphological alterations of electrically stimulated neuroblastoma cells. IEEE Trans Nanobioscience 2004 0.75
197 DNA condensation by partially acetylated poly(amido amine) dendrimers: effects of dendrimer charge density on complex formation. Molecules 2013 0.75
198 Aberrant apoptosis in thyroid epithelial cells from goiter nodules. J Clin Endocrinol Metab 2002 0.75
199 Bioterrorism: relevance to allergy and immunology in clinical practice. J Allergy Clin Immunol 2002 0.75
200 Progress in cancer nanotechnology. Prog Mol Biol Transl Sci 2010 0.75
201 1α,25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death. Endocrinology 1999 0.75
202 Naloxone pro-drug rescues morphine induced respiratory depression in Sprague-Dawley rats. Respir Physiol Neurobiol 2011 0.75
203 Addendum guidelines for the prevention of peanut allergy in the United States. JAAPA 2017 0.75